| Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis AA Agyeman, KL Chin, CB Landersdorfer, D Liew, R Ofori-Asenso Mayo Clinic Proceedings 95 (8), 1621-1631, 2020 | 601 | 2020 |
| Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ... Clinical infectious diseases 57 (4), 524-531, 2013 | 465 | 2013 |
| Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel Clinical pharmacokinetics 48, 89-124, 2009 | 358 | 2009 |
| Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans F Sörgel, R Weissenbacher, M Kinzig-Schippers, A Hofmann, M Illauer, ... Chemotherapy 48 (6), 267-274, 2003 | 283 | 2003 |
| Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new? PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012 | 230 | 2012 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria AP Zavascki, JB Bulitta, CB Landersdorfer Expert review of anti-infective therapy 11 (12), 1333-1353, 2013 | 189 | 2013 |
| ‘Old’antibiotics for emerging multidrug-resistant bacteria PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation Current opinion in infectious diseases 25 (6), 626-633, 2012 | 155 | 2012 |
| Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ... Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005 | 134 | 2005 |
| Development of a new pre-and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT JB Bulitta, A Bingölbali, BS Shin, CB Landersdorfer The AAPS journal 13, 201-211, 2011 | 133 | 2011 |
| Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models CB Landersdorfer, J Wang, V Wirth, K Chen, KS Kaye, BT Tsuji, J Li, ... Journal of Antimicrobial Chemotherapy 73 (2), 462-468, 2018 | 123 | 2018 |
| Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus CB Landersdorfer, WJ Jusko Clinical pharmacokinetics 47, 417-448, 2008 | 120 | 2008 |
| A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections AA Agyeman, PJ Bergen, GG Rao, RL Nation, CB Landersdorfer International journal of antimicrobial agents 55 (1), 105833, 2020 | 119 | 2020 |
| Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling JB Bulitta, NS Ly, CB Landersdorfer, NA Wanigaratne, T Velkov, R Yadav, ... Antimicrobial agents and chemotherapy 59 (4), 2315-2327, 2015 | 109 | 2015 |
| PK/PD models in antibacterial development T Velkov, PJ Bergen, J Lora-Tamayo, CB Landersdorfer, J Li Current opinion in microbiology 16 (5), 573-579, 2013 | 98 | 2013 |
| Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models JB Bulitta, CB Landersdorfer The AAPS journal 13 (2), 212-226, 2011 | 97 | 2011 |
| Colistin: how should it be dosed for the critically ill? CB Landersdorfer, RL Nation Seminars in respiratory and critical care medicine 36 (01), 126-135, 2015 | 92 | 2015 |
| Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design CB Landersdorfer, NS Ly, H Xu, BT Tsuji, JB Bulitta Antimicrobial agents and chemotherapy 57 (5), 2343-2351, 2013 | 85 | 2013 |
| Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ... Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015 | 83 | 2015 |
| Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ... Journal of Antimicrobial Chemotherapy 68 (3), 674-677, 2013 | 83 | 2013 |
| Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system HY Lin, CB Landersdorfer, D London, R Meng, CU Lim, C Lin, S Lin, ... PLoS computational biology 7 (2), e1001073, 2011 | 78 | 2011 |
